Mais Médicos: um programa brasileiro em uma perspectiva internacional FP Oliveira, T Vanni, HA Pinto, JTR Santos, AM Figueiredo, SQ Araújo, ... Interface-Comunicação, Saúde, Educação 19, 623-634, 2015 | 246 | 2015 |
Dengue vector control strategies in an urban setting: an economic modelling assessment PM Luz, T Vanni, J Medlock, AD Paltiel, AP Galvani The Lancet 377 (9778), 1673-1680, 2011 | 193 | 2011 |
Calibrating models in economic evaluation: a seven-step approach T Vanni, J Karnon, J Madan, RG White, WJ Edmunds, AM Foss, R Legood Pharmacoeconomics 29, 35-49, 2011 | 180 | 2011 |
Calibrating models in economic evaluation: a comparison of alternative measures of goodness of fit, parameter search strategies and convergence criteria J Karnon, T Vanni Pharmacoeconomics 29, 51-62, 2011 | 82 | 2011 |
Calibration of disease simulation model using an engineering approach CY Kong, PM McMahon, GS Gazelle Value in health 12 (4), 521-529, 2009 | 71 | 2009 |
Systemic treatment of AIDS-related Kaposi sarcoma: current status and perspectives T Vanni, E Sprinz, MW Machado, RC Santana, BAL Fonseca, ... Cancer treatment reviews 32 (6), 445-455, 2006 | 68 | 2006 |
International scientific collaboration in HIV and HPV: a network analysis T Vanni, M Mesa-Frias, R Sanchez-Garcia, R Roesler, G Schwartsmann, ... PloS one 9 (3), e93376, 2014 | 64 | 2014 |
Economic modelling assessment of the HPV quadrivalent vaccine in Brazil: a dynamic individual-based approach T Vanni, PM Luz, A Foss, M Mesa-Frias, R Legood Vaccine 30 (32), 4866-4871, 2012 | 62 | 2012 |
Avaliação econômica em saúde: aplicações em doenças infecciosas T Vanni, PM Luz, RA Ribeiro, HMD Novaes, CA Polanczyk Cadernos de Saúde Pública 25 (12), 2543-2552, 2009 | 62 | 2009 |
Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trial EG Kallas, AR Precioso, R Palacios, B Thomé, PE Braga, T Vanni, ... The Lancet Infectious Diseases 20 (7), 839-850, 2020 | 61 | 2020 |
Influence of CYP19A1 polymorphisms on the treatment of breast cancer with aromatase inhibitors: a systematic review and meta-analysis O Artigalás, T Vanni, MH Hutz, P Ashton-Prolla, IV Schwartz BMC medicine 13, 1-10, 2015 | 55 | 2015 |
Uncertainty in environmental health impact assessment: quantitative methods and perspectives M Mesa-Frias, Z Chalabi, T Vanni, AM Foss International journal of environmental health research 23 (1), 16-30, 2013 | 54 | 2013 |
Systematic review of model-based cervical screening evaluations D Mendes, I Bains, T Vanni, M Jit BMC cancer 15, 1-11, 2015 | 50 | 2015 |
“Mais Médicos”: a Brazilian program in an international perspective FP Oliveira, T Vanni, HA Pinto, JTR Santos, AM Figueiredo, SQ Araújo, ... Interface-Comunicação, Saúde, Educação 19, 623-634, 2015 | 48 | 2015 |
Estratégias para estimular o uso de evidências científicas na tomada de decisão RISC Dias, JOM Barreto, T Vanni, AMSC Candido, LH Moraes, ... Cadernos Saúde Coletiva 23, 316-322, 2015 | 44 | 2015 |
A cross-sectional study of high-risk human papillomavirus clustering and cervical outcomes in HIV-infected women in Rio de Janeiro, Brazil JL Castilho, JE Levi, PM Luz, MC Cambou, T Vanni, A de Andrade, ... BMC cancer 15, 1-10, 2015 | 39 | 2015 |
Cervical cancer screening among HIV‐infected women: An economic evaluation in a middle‐income country T Vanni, PM Luz, B Grinsztejn, VG Veloso, A Foss, M Mesa‐Frias, ... International Journal of Cancer 131 (2), E96-E104, 2012 | 32 | 2012 |
Cost-effectiveness of implant-supported dental prosthesis compared to conventional dental prosthesis LF Probst, T Vanni, DFB Cavalcante, ET Silva, YW Cavalcanti, LA Passeri, ... Revista de saude publica 53, s1518-8787.2019053001066, 2019 | 28 | 2019 |
Economic evaluation of strategies for managing women with equivocal cytological results in Brazil T Vanni, R Legood, EL Franco, LL Villa, PM Luz, G Schwartsmann International journal of cancer 129 (3), 671-679, 2011 | 27 | 2011 |
Avaliação de tecnologias em saúde no Brasil e no contexto internacional CA Polanczyk, T Vanni, RS Kuchenbecker Avaliação de Tecnologias em Saúde: evidência clínica, análise econômica e …, 2010 | 23 | 2010 |